CPRX


Catalyst Pharma To Buy Back $40M In Stock; Shares Gain Pre-Market

Shares of Catalyst Pharma rose more than 3% in the pre-market session after the commercial-stage biopharmaceutical company announced its stock repurchase program of …

Catalyst Pharma 4Q Revenue, Earnings Outperform Estimates

Catalyst Pharmaceuticals delivered a better-than-expected 4Q performance, driven by higher sales for Firdapse, which is used to treat Lambert-Eaton myasthenic syndrome (LEMS) patients. …

Healthcare Pro Steven Boyd Is Gobbling Up These 3 Stocks

With the market’s trajectory remaining unknown, hedge fund manager Steven Boyd believes that one industry in particular still houses exciting opportunities: the healthcare …

3 ‘Strong Buy’ Stocks to Buy on Weakness

Investors are constantly searching for the next big winner. We mean the stocks that are on track to see explosive growth, handsomely rewarding …

Here’s Why Analysts Remain Confident on Catalyst (CPRX) Stock

This week turned out to be a nightmare for shareholders of Catalyst Pharmaceuticals (CPRX), as the stock price plummeted over 50%. So what …

Spooked Investors Sent Catalyst (CPRX) Stock Spiraling, But Analysts Remain Confident

This week turned out to be a nightmare for shareholders of Catalyst Pharmaceuticals (CPRX), as the stock price plummeted nearly 55%. What’s causing …

Catalyst Pharmaceuticals (CPRX) Stock Receives Upbeat Wall Street Comments

Catalyst Pharmaceuticals (CPRX) hosted a conference call yesterday to discuss its commercialization plan for the company’s newly FDA-approved LEMS drug, Firdapse. Catalyst announced …

Analyst Predicts Success for Catalyst Pharmaceutical (CPRX ) Stock Following News of Latest FDA Approval

Catalyst Pharmaceutical (CPRX) stock fell about 8% between Thursday and Friday. Even though the company just announced its first FDA approval for Firdapse, …

Catalyst Pharmaceuticals (CPRX): A Biotech Stock This Analyst Is Closely Watching

Every small-cap biotechnology investor knows the industry is prone to binary events. Whether it’s receiving updates from an important clinical trial or hearing …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts